Insulin Production Technology
Find innovative production technology for making insulin and connect directly with world-leading specialists.
Insulin is a hormone that controls blood glucose levels produced by the beta cells in the pancreas. As a medication, insulin was discovered by Frederick Banting and Charles Best in 1921, for which Banting was awarded a Nobel Prize in 1923. The insulin production process involves manipulating the biological precursor to insulin and cultivating it inside bacteria using specialized technology.
Which insulin equipment do you need?
High-frequency vibratory mixer
Mixing liquid products by stirring method generates heat from friction and shear forces. This …
Cold forming aluminum blister machine for capsules
Aluminum blisters are mainly used for packaging products that are sensi…
Automated bubble traps for chromatography
Radial flow chromatography processes require special attention and the right use …
Pre-packed and pre-validated chromatography columns
In chromatography, you must always take into account the apparatus tha…
Lab-scale radial chromatography columns for virus validation
In the food industry, as an example, during lab-testing and …
Complete bioreactor system
An autoclavable bioreactor establishes special conditions for a variety of applications, for examp…
Optical Dissolved Oxygen Sensors
Sufficient oxygen is critical to the success of processes like cell culture and fermentation…
Bioprocess control software
Managing a large number of bioprocesses individually without automation is time-consuming, and th…
Bioreactor software
Comprehensive upstream data acquisition and management are essential in the bioprocessing industry. That’…
Single use bioreactor
Single use, micro-bioreactors could be a good solution for replication processes, especially when they e…
Closed restricted access barrier system
Pharmaceutical production techniques often require isolation of compounds and chemic…
Visual and HVLD inspection for ampoules, vials and cartridges
Do you need to improve the efficiency and capability of you…
Semi-automatic inspection machine for ampoules, vials or cartridges
If you need to increase the efficiency of your manua…
Small automatic inspector for ampoules, vials, or cartridges
Inspect small batch production of ampoules, vials, or cartri…
Flexible automatic inspection machine for ampoules, vials, cartridges
If you are looking to improve the efficiency of yo…
Flexible automatic inspection machine for syringes
Manufacture of pre-filled syringes requires the highest quality inspect…
24 fully controlled bioreactors in a microtiter format
When undertaking a screening study, process development or optimisa…
Compact H2O2 disinfection system
Dry fogging provides safe, effective microbiological cleaning of critical areas in biotech, …
Purification screening kit for large biomolecules
To purify a specific large biomolecule, for example IgM or a virus or vi…
Plasmid process pack for your pDNA purification process
When developing a pDNA purification process for eventual transfer …
Short bed monolithic columns for analytics
Samples taken at various process steps need to be analysed quickly and accurate …
Disposable monolithic columns
Chromatographic monolithic columns for working with large proteins, viruses, VLPs and pDNA requ…
High-speed aseptic injectable vial filling machine
Fill up to 24,000 vials per hour with pharmaceutical powders or liquids…
Should your technology be listed here?
Can your technology help make this product better?
Sign upAutomated cell culture clarification system
Efficient harvest from the bioreactor is essential to any successful cell cultu…
Single-use temperature sensor
Biopharmaceutical manufacturers are increasingly making use of single-use temperature sensors t…
Single-use conductivity sensor
Biopharmaceutical manufacturers are increasingly making use of single-use conductivity sensors…
Single-use pressure sensor
Biopharmaceutical manufacturers are increasingly making use of Single-use pressure sensors to enha…
Automated dispensing system for bioprocesses
Biopharmaceutical manufacturers require precisely known liquid quantities for …
Lab scale normal flow filtration system
Normal Flow Filtration is frequently used the biopharmaceutical processing industry …
Lab scale tangential flow filtration system
Tangential Flow Filtration is an essential to the biopharmaceutical processing …
Bag holder and weighing platform for bioprocesses
Single use bags for biopharmaceutical process containment and liquid sto…
Semi-automated normal flow filtration system
Normal Flow Filtration is frequently used the biopharmaceutical processing ind…
Semi-automated tangential flow filtration system
Tangential Flow Filtration is an essential to the biopharmaceutical proces…
Automated single use tangential flow filtration system
Tangential Flow Filtration is an essential to the biopharmaceutical…
Disposable tubing for manifolds in bioprocesses
Manufacturers in the bioprocessing industries are increasingly turning to s…
There is currently no equipment listed with your specified properties, but we are sure we can help you. Try us!Contact us
Select your insulin process
Too much choice? Don't worry, we got you!
Connect directly with world leading technology suppliers.
We will connect you directly with a technology specialist that has experience with your process.
Contact usThe differences between animal-derived insulin and human insulin
Insulin injections are used for managing blood sugar levels in individuals who can’t naturally produce insulin. For many years, using insulin derived from animals, mainly porcine or bovine pancreases was the norm, but the production of human insulin became a more popular alternative since its discovery in the 1980s. Manufacturing biosynthetic human insulin via gene technologies is a preferred method for not having to depend on animals as well as the possibility to produce unlimited amounts by multiplying the insulin gene inside bacteria.
Aside from production efficiency, as extracting large amounts from animal tissue is challenging, some issues with animal-derived insulin production are related to the raw animal tissues and diseases such as Bovine Spongiform Encephalopathy (BSE) and Transmissible Spongiform Encephalopathy (TSE) and possible cross-contamination through injections. Furthermore, the chemical differences between human and animal insulin can lead to antibody attacks, inactivation and inflammation.
However, a shortage of animal-sourced insulin in developed countries is a concern for a small number of individuals who experience severe hypoglycemic episodes when using biosynthetic insulin, and generally feel healthier when undergoing an animal-derived insulin treatment.
The steps and technology in recombinant insulin production processes
Recombinant DNA is a technology for the large-scale production of insulin by inserting the human gene which carries codes for the protein insulin into a plasmid of a simple bacteria, most commonly Escherichia coli. Producers then add ligase, an enzyme that acts like glue to help the plasmid stick to the bacterium’s DNA. The bacteria undergo a fermentation process inside a large fermentation tank, where millions of bacteria replicate every 20 minutes. The insulin harvest starts by adding a mixture of lysozyme which digests the outer layer of the cell wall and a detergent mixture which separates the fatty cell wall membrane.
The insulin is separated from the bacterium’s DNA with the help of a cyanogen bromide treatment which splits protein chains at the methionine residues. An oxidizing agent is added and the mixture is placed in a centrifuge to separate cell components. The DNA mixture is purified by using one of the following techniques: ion-exchange column, reverse-phase high-performance liquid chromatography or a gel filtration chromatography column. Finally, the purified substance is ready for medical use.
The future of insulin patents and treatment delivery
Although the use of insulin pens is a practical therapy due to their reusable nature, ability to increase patient compliance and accuracy, and there are innovative solutions to enhance the delivery of insulin in the future. An alternative for diabetes care would be oral application, however, scientists are looking for ways to avoid enzymatic degradation upon consumption. Solutions can be found in nanoparticle-based approaches which protect insulin from gastrointestinal conditions and enhance the permeability of the enzyme.
A further option is the bioresponsive insulin delivery system, which accelerates insulin release with increasing glucose levels. Furthermore, manufacturers are working on the production of inhaled insulin devices, with insulin particles small enough to reach the deep lung and pass into the bloodstream. Another aerosol option is buccal insulin, a spray absorbed through the inner cheek wall. Finally, absorbing insulin through the skin with the help of insulin patches is another idea in development.
Transgenic plants as a solution for high demand
The insulin production process and its current manufacturing technologies struggle to keep up with the steadily increasing demand for affordable insulin due to a rising number of patients with diabetes. This is especially the case in the United States. One of the most effective alternatives is the manufacture of recombinant human insulin from the plant Arabidopsis Thaliana and its oilseeds. Plant-based insulin is easy to produce, cost-effective, free from human pathogens and involves high-quality protein processing.
The oilseeds are genetically engineered with the recombinant protein targeting oil bodies and then processed by separating oil bodies via liquid-liquid phase to reduce chromatography steps in the purification of insulin. Transgenic plants can produce a high level of biologically active proinsulin and it can further be enzymatically treated in vitro which is an economic method for mass production.